Brussels, April 12 (Reuters) - the Eu's Executive Commission Approved Illumina's Ilmn.o Plan to Unwind Its Completed Acquisition of Cancer Diagnostic Test Maker Grail Gral.o, It Said in a Statement on Friday.
布魯塞爾，4月12日（路透社）——歐盟執行委員會批准了Illumina的 ILMNO 計劃結束對癌症診斷測試製造商Grail的已完成收購 Gralo。，它在週五的一份聲明中說。
the U.S. Gene Sequencing Company Illumina Had Announced Late Last Year to Divest Grail, After the Companies Battled Both U.S. and European Antitrust Enforcers for More Than Two Years and Faced Fierce Opposition From Activist Investor Carl Icahn.
美國基因測序公司 Illumina Had 已宣佈 去年年底將剝離Grail，此前兩家公司與美國和歐洲的反壟斷執法機構作鬥爭了兩年多，並遭到了激進投資者卡爾·伊坎的強烈反對。
(Writing by Nette Nöstlinger, Editing by Charlotte Van Campenhout)
（由內特·諾斯特林格撰寫，夏洛特·範·坎彭豪特編輯）